Balchem Stock Forecast, Price & News

Balchem (NASDAQ:BCPC) Frequently Asked Questions

Is Balchem a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Balchem stock.
View analyst ratings for Balchem or view top-rated stocks.

How has Balchem's stock price been impacted by COVID-19?

Balchem's stock was trading at $89.29 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BCPC shares have increased by 85.1% and is now trading at $165.28.
View which stocks have been most impacted by COVID-19.

When is Balchem's next earnings date?

Balchem is scheduled to release its next quarterly earnings announcement on Friday, February 18th 2022.
View our earnings forecast for Balchem.

How were Balchem's earnings last quarter?

Balchem Co. (NASDAQ:BCPC) announced its earnings results on Thursday, October, 28th. The basic materials company reported $0.92 EPS for the quarter, topping the Zacks' consensus estimate of $0.90 by $0.02. The basic materials company earned $197.87 million during the quarter, compared to analyst estimates of $204.80 million. Balchem had a net margin of 12.17% and a trailing twelve-month return on equity of 13.46%. During the same period last year, the company earned $0.83 earnings per share.
View Balchem's earnings history.

How often does Balchem pay dividends? What is the dividend yield for Balchem?

Balchem declared an annual dividend on Thursday, December 17th. Investors of record on Monday, December 28th will be given a dividend of $0.58 per share on Friday, January 22nd. This represents a dividend yield of 0.5%. The ex-dividend date is Thursday, December 24th. This is an increase from Balchem's previous annual dividend of $0.26.
View Balchem's dividend history.

Is Balchem a good dividend stock?

Balchem pays an annual dividend of $0.58 per share and currently has a dividend yield of 0.34%. Balchem has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Balchem is 20.21%. This payout ratio is at a healthy, sustainable level, below 75%.
View Balchem's dividend history.

What price target have analysts set for BCPC?

2 analysts have issued 1-year price objectives for Balchem's shares. Their forecasts range from $145.00 to $160.00. On average, they expect Balchem's stock price to reach $152.50 in the next twelve months. This suggests that the stock has a possible downside of 7.7%.
View analysts' price targets for Balchem or view top-rated stocks among Wall Street analysts.

Who are Balchem's key executives?

Balchem's management team includes the following people:

• Theodore L. Harris, Chairman, President & Chief Executive Officer
• Martin Bengtsson, Chief Financial Officer & Treasurer
• Jeff McCartney, Senior Director-Information Technology
• Michael Sestrick, Chief Technology Officer
• James Hyde, SVP & General Manager-Human Health & Nutrition

What is Dino A. Rossi's approval rating as Balchem's CEO?

15 employees have rated Balchem CEO Dino A. Rossi on Glassdoor.com. Dino A. Rossi has an approval rating of 85% among Balchem's employees.

Who are some of Balchem's key competitors?

Some companies that are related to Balchem include Sherwin-Williams (SHW), Ecolab (ECL), International Flavors & Fragrances (IFF), Albemarle (ALB), Celanese (CE), RPM International (RPM), Ashland Global (ASH), Quaker Chemical (KWR), Sensient Technologies (SXT), H.B. Fuller (FUL), NewMarket (NEU), Stepan (SCL), Valaris (VAL), Minerals Technologies (MTX) and Innospec (IOSP).
View all of BCPC's competitors.

What other stocks do shareholders of Balchem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL), CVS Health (CVS), AbbVie (ABBV), Johnson & Johnson (JNJ), Lowe's Companies (LOW), Altria Group (MO), NVIDIA (NVDA), AT&T (T), Analog Devices (ADI) and Bristol-Myers Squibb (BMY).

What is Balchem's stock symbol?

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Who are Balchem's major shareholders?

Balchem's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.67%), Wasatch Advisors Inc. (5.65%), Conestoga Capital Advisors LLC (3.08%), Geneva Capital Management LLC (2.06%), Schroder Investment Management Group (1.80%) and Geode Capital Management LLC (1.72%). Company insiders that own Balchem stock include Scott C Mason and William A Backus.
View institutional ownership trends for Balchem.

Which institutional investors are selling Balchem stock?

BCPC stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Schroder Investment Management Group, New York State Common Retirement Fund, Macquarie Group Ltd., Morgan Stanley, Eaton Vance Management, Assenagon Asset Management S.A., and Segall Bryant & Hamill LLC.
View insider buying and selling activity for Balchem or view top insider-selling stocks.

Which institutional investors are buying Balchem stock?

BCPC stock was purchased by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Allianz Asset Management GmbH, Nordea Investment Management AB, Conestoga Capital Advisors LLC, BNP Paribas Arbitrage SA, Goldman Sachs Group Inc., Invesco Ltd., and Skandinaviska Enskilda Banken AB publ .
View insider buying and selling activity for Balchem or or view top insider-buying stocks.

How do I buy shares of Balchem?

Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Balchem's stock price today?

One share of BCPC stock can currently be purchased for approximately $165.28.

How much money does Balchem make?

Balchem has a market capitalization of $5.35 billion and generates $703.64 million in revenue each year. The basic materials company earns $84.62 million in net income (profit) each year or $2.87 on an earnings per share basis.

How many employees does Balchem have?

Balchem employs 1,342 workers across the globe.

When was Balchem founded?

Balchem was founded in 1967.

What is Balchem's official website?

The official website for Balchem is www.balchem.com.

Where are Balchem's headquarters?

Balchem is headquartered at 52 Sunrise Park Road, NEW HAMPTON NY, 10958.

How can I contact Balchem?

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at (845) 326-5600, via email at [email protected], or via fax at 845-326-5717.